News
2025 EPHMRA Basel Chapter Meeting: “When something clicks: Fusing data to fuel deeper insight”
One of the key takeaways from the paper by Sarah Brown and Mariel Metcalfe of Research Partnership, which is called “When something clicks: Fusing data to fuel deeper
Post Conference News now available
Visit the EPHMRA website using the link below, to access our quarterly news archive. This includes, write ups from all the June papers.
https://www.ephmra.org/resources-page/newsletters-our-quarterly-news-ar…
EPHMRA 2025 Germany Chapter meeting – send us your ideas for papers
We are happy to announce the 14th Germany Chapter meeting for 2025 which will be held as an in-person meeting in Berlin.
Paper announcement for the 2024 Basel Chapter meeting!
Rebekah Park, Gemic will be presenting her paper: ‘The Patient Life Experience (PLE) Approach: Using social science methodology to examine diverse patient lives and reduce health disparities’
Agency members…
By now you should have received your invoice for your Membership renewal. If you haven’t seen one in your inbox, let us know as soon as possible by emailing generalmanager@ephmra.org.
Would you like to have the opportunity to influence the future of EPHMRA?
As a member, you will have chance to share your views and expertise by playing an active role on Committees that liaise with the Board.
Along with helping members achieve professional excellence, our Committees support their needs by sharing best practice, and keeping them up to date with industry developments.
Send in your Synopsis for the 2025 Conference, 24 - 26 June, London
The Call for Papers is Launched! Submission deadline is 23 September 2024
The 2024 Conference was a great success and we are now excited to plan our June 2025 event. Can you add your voice by submitting an idea for a paper?
Basel meeting on 19 September 2024
‘Analysing the impact of Health Inequality: Unravelling the Business Question’
Meeting Convenors:
Ana Maria Aguirre-Arteta, Novartis
The 2024 Adverse Event Reporting Guidelines are now available.
The EPHMRA AER Guidelines have been written for Marketing Authorisation Holders (MAH/CH) or Certificate Holders and market research agencies (MRA) on the collection and reporting of an Adverse Event (AE) of medicinal products and medical devices.
Our final paper to be announced for the 2024 EPHMRA Basel Chapter meeting is entitled: Ethnic Disparities in Multiple Myeloma Treatment: A Holistic Analysis from Real-World Data.